Literature DB >> 1357346

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

B C Martin1, J H Warram, A S Krolewski, R N Bergman, J S Soeldner, C R Kahn.   

Abstract

Type 2 diabetes mellitus is characterised by resistance of peripheral tissues to insulin and a relative deficiency of insulin secretion. To find out which is the earliest or primary determinant of disease, we used a minimum model of glucose disposal and insulin secretion based on intravenous glucose tolerance tests to estimate insulin sensitivity (SI), glucose effectiveness (ie, insulin-independent glucose removal rate, SG), and first-phase and second-phase beta-cell responsiveness in normoglycaemic offspring of couples who both had type 2 diabetes. 155 subjects from 86 families were followed-up for 6-25 years. More than 10 years before the development of diabetes, subjects who developed the disease had lower values of both SI (mean 3.2 [SD 2.4] vs 8.1 [6.7] 10(-3) I min-1 pmol-1 insulin; p < 0.0001) and SG (1.6 [0.9] vs 2.3 [1.2] 10(-2) min-1, p < 0.0001) than did those who remained normoglycaemic). For the subjects with both SI and SG below the group median, the cumulative incidence of type 2 diabetes during the 25 years was 76% (95% confidence interval 54-99). By contrast, no subject with both SI and SG above the median developed the disease. Subjects with low SI/high SG or high SI/low SG had intermediate risks. Insulin secretion, especially first phase, tended to be increased rather than decreased in this prediabetic phase and was appropriate for the level of insulin resistance. The development of type 2 diabetes is preceded by and predicted by defects in both insulin-dependent and insulin-independent glucose uptake; the defects are detectable when the patients are normoglycaemic and in most cases more than a decade before diagnosis of disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357346     DOI: 10.1016/0140-6736(92)92814-v

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  270 in total

Review 1.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Gene expression in the pathophysiology of type 2 diabetes mellitus.

Authors:  Mary-Elizabeth Patti
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

3.  A spectrum of dynamic insulin sensitivity test protocols.

Authors:  Paul D Docherty; J Geoffrey Chase; Lisa Te Morenga; Thomas F Lotz; Juliet E Berkeley; Geoffrey M Shaw; Kirsten A McAuley; Jim I Mann
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

4.  High-intensity exercise and carbohydrate-reduced energy-restricted diet in obese individuals.

Authors:  Francesco Sartor; Helma M de Morree; Verena Matschke; Samuele M Marcora; Athanasios Milousis; Jeanette M Thom; Hans-Peter Kubis
Journal:  Eur J Appl Physiol       Date:  2010-07-14       Impact factor: 3.078

5.  A Bayesian population analysis of the development of type 2 diabetes in the offspring of diabetic parents.

Authors:  C W Lin; J H Warram; P Veng-Pedersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-08-11       Impact factor: 2.745

6.  The adverse effects of chronic low-dose exposure to nonylphenol on type 2 diabetes mellitus in high sucrose-high fat diet-treated rats.

Authors:  Jie Yu; Jin Yang; Ya Luo; Yang Mengxue; Wenmei Li; Yu Yang; Liting He; Jie Xu
Journal:  Islets       Date:  2017-12-07       Impact factor: 2.694

Review 7.  Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.

Authors:  Richard E Pratley; Christian Weyer
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

8.  Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance.

Authors:  C Guerra; P Navarro; A M Valverde; M Arribas; J Brüning; L P Kozak; C R Kahn; M Benito
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

9.  Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

Authors:  D A D'Alessio; S E Kahn; C R Leusner; J W Ensinck
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 10.  Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.

Authors:  C Oosterwijk; J W Höppener; K L van Hulst; C J Lips
Journal:  Int J Pancreatol       Date:  1995-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.